{
    "title": "Novartis loses in patent appeal over multiple sclerosis drug",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10938445/Novartis-loses-patent-appeal-multiple-sclerosis-drug.html",
    "date": "2022-06-21",
    "keywords": [
        "patent",
        "gilenya",
        "novartis",
        "decision",
        "drug",
        "circuit",
        "brittain",
        "court",
        "tuesday",
        "drugmaker",
        "sclerosis",
        "way",
        "version",
        "panel",
        "hec",
        "blake",
        "june",
        "introduction",
        "medicine",
        "ruling",
        "case",
        "finding",
        "pharm",
        "cos",
        "bid",
        "year",
        "companys",
        "company",
        "statement",
        "appeal",
        "process",
        "comment",
        "upheld",
        "delaware",
        "hecs",
        "use",
        "dosage",
        "fingolimod",
        "split",
        "expiration",
        "market",
        "jonathan",
        "stempel",
        "york",
        "washington",
        "editing",
        "nomiyama",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}